Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,119,756    

Indirect Value

   $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634 Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 55 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp 10% Owner   –       –       •   2003-09-19 4 B $5.04 $2,649,672 I/I 526,000 1,412,855 1.5 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-05-28 4 B $1.56 $862,159 I/I 538,649 6,432,782 1.5 -
INCY Incyte Corp 10% Owner   –       –       •   2003-09-19 4 B $5.04 $2,802,557 I/I 556,350 1,020,307 1.5 -
SGEN Seagen Inc Director   –       •       •   2008-01-18 4 B $9.00 $5,040,423 I/I 560,047 3,814,564 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-10-13 4 D $0.00 $0 I/I (586,556) 1,144,755 -
INCY Incyte Corp Director   –       •       •   2010-09-21 4 S $14.94 $9,116,306 I/I (610,072) 7,917,761 0 -
SGEN Seagen Inc Director   –       •       •   2007-02-14 4 A $0.00 $0 I/I 617,000 2,152,999 0 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-21 4 B $15.50 $10,965,599 I/I 707,458 2,445,557 2.25 -
SGEN Seagen Inc Director   –       •       •   2009-05-20 4 B $9.72 $7,256,670 I/I 746,571 8,684,009 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2009-02-06 4 S $8.17 $6,148,420 I/I (752,204) 5,771,961 0 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-06-19 4 S $5.64 $4,297,713 I/I (755,352) 6,073,545 0 -
INCY Incyte Corp Director   –       •       •   2022-02-10 4 B $66.57 $55,276,314 I/I 819,015 31,752,130 2.25 %
SGEN Seagen Inc Director   –       •       •   2006-05-24 4 B $5.25 $4,368,709 I/I 832,135 1,515,043 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-01-29 4 B $6.00 $5,029,776 I/I 838,296 2,557,090 1.5 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-04-29 4 B $12.98 $10,987,554 I/I 844,061 2,737,856 1.5 -
GEVA Synageva BioPharma Corp Director   –       •       •   2013-01-04 4 B $47.53 $40,862,492 I/I 859,720 176,920 2.25 -
INCY Incyte Corp Director   –       •       •   2008-07-31 4 B $9.00 $7,776,828 I/I 864,092 6,291,968 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-07-13 4 B $41.20 $36,503,200 I/I 886,000 156,821 2.25 -
SGEN Seagen Inc Director   –       •       •   2007-02-14 4 A $0.00 $0 I/I 925,000 5,074,611 0 -
SGEN Seagen Inc Director   –       •       •   2011-08-25 4 B $15.35 $15,253,844 I/I 984,850 14,646,893 2.25 -
SGEN Seagen Inc Director   –       •       •   2007-02-14 4 S $8.72 $8,718,099 I/I (999,782) 1,153,217 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2015-01-07 4 B $94.19 $94,190,000 I/I 1,000,000 9,184,771 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2013-09-25 4 B $56.63 $59,461,500 I/I 1,050,000 202,583 2.25 -
INCY Incyte Corp Director   –       •       •   2011-12-05 4 B $13.88 $14,883,177 I/I 1,071,825 11,000,714 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-01-05 4 A $25.18 $27,124,526 I/I 1,077,225 5,077,676 0 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55  56      
  Page 55 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us